SAN DIEGO, July 16, 2025--(BUSINESS WIRE)--Revelation Biosciences, Inc. (NASDAQ: REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company focused on rebalancing inflammation to ...
SAN DIEGO--(BUSINESS WIRE)--Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on harnessing the power of trained ...
Hundreds of people lined up outside San Francisco’s Commonwealth Club recently, braving protesters in demon masks blasting death metal, all to hear billionaire Peter Thiel deliver a lecture about the ...
(RTTNews) - Revelation Biosciences Inc. (REVB) is preparing to showcase new clinical data that could mark an important step forward in the treatment of kidney disease. The company announced that ...
Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company developing innovative solutions to treat acute and chronic disease, today announced ...
PARIS, France—(UPDATED) A small, randomized trial may breathe new life into the concept of using a drug-coated balloon (DCB) instead of a stent in acute MI, particularly in younger patients with ...
-Revelation to host conference call and webcast at 4:30 p.m. Eastern Time on January 11, 2022. The conference call can be accessed by dialing 877-815-0146 for domestic callers and 631-625-3219 for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results